reviewJournal of Obesity & Metabolic SyndromeSep 13, 2023DIAMOND OA

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review

University of Malaya · Chinese University of Hong Kong · +1 more institution

PubMed
Indexed incrossrefdoajpubmed

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for steatotic liver disease associated with metabolic syndrome. MASLD is the most common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality. It is important that all stakeholders be involved in tackling the public health threat of obesity and obesity-related diseases, including MASLD. A simple and clear assessment and referral pathway using non-invasive tests is essential to ensure that patients with severe MASLD are identified and referred to specialist care, while patients with less severe disease remain in primary care, where they are best managed. While lifestyle intervention is…

Citation impact

656
total citations
FWCI
133.63
Percentile
100%
References
127
Citations per year

Authors

6

Topics & keywords

Keywords
  • Medicine
  • Metabolic syndrome
  • Cirrhosis
  • Intensive care medicine
  • Liver disease
  • Disease
  • Fatty liver
  • Diabetes mellitus
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.